AeroLeads people directory · profile

Anna-Karin Sternbeck Email & Phone Number

Assessor Pharmacokinetics at Medical Products Agency Läkemedelsverket
Location: Greater Stockholm Metropolitan Area, Sweden 9 work roles 2 schools
1 work email found @ri.se LinkedIn matched
✓ Verified August 2026 4 data sources Profile completeness 100%

Contact Signals · 1 work email

Work email a****@ri.se
LinkedIn Profile matched
3 free lookups remaining · No credit card
Role
Assessor Pharmacokinetics
Location
Greater Stockholm Metropolitan Area, Sweden
Company size

Who is Anna-Karin Sternbeck? Overview

A concise factual answer block for searchers comparing this professional profile.

Quick answer

Anna-Karin Sternbeck is listed as Assessor Pharmacokinetics at Medical Products Agency Läkemedelsverket, a with 970 employees, based in Greater Stockholm Metropolitan Area, Sweden. AeroLeads shows a work email signal at ri.se and a matched LinkedIn profile for Anna-Karin Sternbeck.

Anna-Karin Sternbeck previously worked as Projektledare at Rise Research Institutes Of Sweden and Researcher/Project Leader at Rise Research Institutes Of Sweden. Anna-Karin Sternbeck holds Phd, Biochemical Toxicology from Stockholm University.

Company email context

Email format at Medical Products Agency Läkemedelsverket

This section adds company-level context without repeating Anna-Karin Sternbeck's masked contact details.

asternbeck@ri.se
76% confidence

AeroLeads found 1 current-domain work email signal for Anna-Karin Sternbeck. Compare company email patterns before reaching out.

Profile bio

About Anna-Karin Sternbeck

Experienced scientist with a demonstrated history of working in the pharmaceutical industry. Many years' experiences of discovery and early development work in the roles as a Principal Scientist, Team Leader and Preclinical DMPK Project Leader. Since 2019 a researcher at the Research Institutes of Sweden. Customer-oriented with commitment to reaching project goals in an interdisciplinary environment. Experience includes:• Collaboration across disciplines• Coordination of studies during project progression• Outsourcing of studies• ADME support and guidance to customers• In silico predictions of physicochemical and ADME parameters• Analysis of pharmacokinetic parameters• Toxicokinetic evaluations according to Good Laboratory Practice (GLP)• Extensive experience of in vitro and in vivo ADME studies and of physicochemical studies• Method development and optimization• DMPK strategy planning and implementation• Prediction of in vivo clearance from in vitro parameters• Early dose to man predictions based on integration of data in the discovery phase• Evaluation of drug-drug interactions in vitro and in vivo• Extensive use of Phoenix WinNonlin, ADMET predictor, GastroPlus and D360• Study director for in vitro and in vivo studies• Documentation and report writing• Excel template development, e.g., for data reporting, result handling and calculations, as well as templates for planning of activities• Teaching• Supervision of students and junior scientists• Peer reviewer of scientific manuscripts• Preclinical DMPK project leadership• Science team leadershipExamples of achievements:• Active role in several project transitions• A leading role in the standardization and implementation of a strategy for in vitro to in vivo prediction of clearance globally within AstraZeneca (a cross-site project)• Actively involved harmonization and implementation of DMPK strategies, globally within AstraZeneca (a cross-site project)• Led the development and implementation of a strategy for reactive metabolites at Medivir

Listed skills include Adme, Dmpk, Team Leadership, Teamwork, and 42 others.

Current workplace

Anna-Karin Sternbeck's current company

Company context helps verify the profile and gives searchers a useful next step.

Medical Products Agency Läkemedelsverket
Medical Products Agency Läkemedelsverket
Assessor Pharmacokinetics
Stockholm, SE
Website
Employees
970
AeroLeads page
9 roles · 32 years

Anna-Karin Sternbeck work experience

A career timeline built from the work history available for this profile.

Principal Scientist, Dmpk

Huddinge, Sweden

DMPK project leaderDMPK work meeting leaderCoordinator of in vitro and in vivo DMPK studiesCoordinator of PhysChem studiesCoordinator of CRO studiesIT representative for the DMPK departmentInternal SimulationPlus coordinatorGastroPlus superuserADMET Predictor superuserD360 superuserExcel template developer

Dec 2012 - Feb 2019

Adme Science Team Leader, Associate Principal Scientist, Phd

Södertälje, Sweden

ADME Science team leader of a group of 14 scientists (2011-2012)Metabolism Science team leader of a group of 11 scientists (2006-2011)Site representative in the AstraZeneca Drug Disposition network (2011-2012)Actively involved in a global initiative to develop a single system for the application of IVIVE (In vitro to In vivo extrapolations) to intrinsic clearance measurements, and the implementation of this method at all AstraZeneca sites (2009-2012)Planned ADME studies and interpreted results (2006-2012)Member of a scientific group within the DxDMPK department in Södertälje with the remit to provide guidelines to projects regarding intestinal bioavailability (2010-2011)Leader of a clearance scaling initiative within the DxDMPK department in Södertälje (2008-2009)Part of the Steering Committee of a post-doc program at AstraZeneca (2011-2012)

2006 - Nov 2012

Pre-Clinical Dmpk Project Leader, Associate Principal Scientist, Phd

Södertälje, Sweden

Interpreted complex data and identified DMPK properties of chemical seriesPlanned studies to solve DMPK issuesPresented DMPK project data at disciplinary and interdisciplinary meetingsWas actively involved in interdisciplinary collaborationsCoached more junior scientistsAdditional: Performed hepatocyte special studies and exploratory experiments (2002-2006)

2002 - 2007 ~5 yrs

Associate Principal Scientist

2000 - 2001 ~1 yr

Senior Research Scientist

Astra Pain Control

Södertälje, Sweden

Performed hepatocyte special studies and exploratory experiments

1997 - 1999 ~2 yrs

Research Scientist

Stockholm, Sweden

Studied the effect of perfluoro fatty acids in cell lines and in miceTaught biochemical toxicology

1995 - 1996 ~1 yr
2 education records

Anna-Karin Sternbeck education

Phd, Biochemical Toxicology

Studied the effect of perfluoro fatty acids in cell lines and in mice

FAQ

Frequently asked questions about Anna-Karin Sternbeck

Quick answers generated from the profile data available on this page.

What company does Anna-Karin Sternbeck work for?

Anna-Karin Sternbeck works for Medical Products Agency Läkemedelsverket.

What is Anna-Karin Sternbeck's role at Medical Products Agency Läkemedelsverket?

Anna-Karin Sternbeck is listed as Assessor Pharmacokinetics at Medical Products Agency Läkemedelsverket.

What is Anna-Karin Sternbeck's email address?

AeroLeads has found 1 work email signal at @ri.se for Anna-Karin Sternbeck at Medical Products Agency Läkemedelsverket.

Where is Anna-Karin Sternbeck based?

Anna-Karin Sternbeck is based in Greater Stockholm Metropolitan Area, Sweden while working with Medical Products Agency Läkemedelsverket.

What companies has Anna-Karin Sternbeck worked for?

Anna-Karin Sternbeck has worked for Medical Products Agency Läkemedelsverket, Rise Research Institutes Of Sweden, Medivir Ab, Astrazeneca, and Astra Pain Control.

How can I contact Anna-Karin Sternbeck?

You can use AeroLeads to view verified contact signals for Anna-Karin Sternbeck at Medical Products Agency Läkemedelsverket, including work email, phone, and LinkedIn data when available.

What schools did Anna-Karin Sternbeck attend?

Anna-Karin Sternbeck holds Phd, Biochemical Toxicology from Stockholm University.

What skills is Anna-Karin Sternbeck known for?

Anna-Karin Sternbeck is listed with skills including Adme, Dmpk, Team Leadership, Teamwork, Drug Metabolism, Drug Discovery, In Vitro To In Vivo Extrapolations, and Hepatocytes.

Find 750M verified contacts

Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.